Analytical Validation of an Annotation Tool for WGS‐Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology
Clinical and Translational Science · 2026-04 · 19 (4)
DOI: 10.1111/cts.70540 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical and Translational Science, online erschienen am 17.04.2026. Verfasst von Meta H M Diekstra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Pharmacogenetics, Whole Genome Sequencing, Neoplasms, Molecular Sequence Annotation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Stichting Prinses Máxima Centrum Foundation.
Abstract (Originalsprache)
Whole genome sequencing (WGS) is increasingly accessible in clinical practice, enabling pharmacogenomics (PGx) integration, including in pediatric oncology. However, the lack of validated software to accurately annotate clinically actionable PGx variants from WGS limits routine implementation. We therefore aimed to identify and validate a PGx annotation tool suitable for clinical use in pediatric oncology. We evaluated several tools for technical performance and clinical integration. The Pharmacogenomics Clinical Annotation Tool (PharmCAT) was selected for its alignment with expert‐reviewed PGx guidelines, inclusion of relevant gene‐drug pairs and prescribing recommendations. PharmCAT was validated using an in silico dataset by introducing known diplotypes into the Genome in a Bottle (GIAB) reference sample, complemented by four clinically confirmed diplotypes from three patients. Diplotype and phenotype outputs from WGS were compared against the GIAB and patient reference data. We tested 71 diplotypes across seven genes ( TPMT , NUDT15 , CYP3A5 , CYP2C9 , CYP2C19 , DPYD , UGT1A1 ), using ≥ 95% sensitivity and specificity as validation criteria. CYP2D6 was excluded from this validation due to genotyping limitations from the input data used by PharmCAT. The tool was integrated into our WGS analysis pipeline using containerization for consistent, reproducible execution. Diplotype and phenotype results from PharmCAT fully matched the in silico GIAB set and patient samples, achieving 100% sensitivity and specificity. These findings confirm PharmCAT as a reliable tool for preemptive PGx annotation, supporting implementation in pediatric oncology. Its clinical integration supports individualized dosing, reducing adverse effects and improving efficacy. Further validation of additional gene‐drug pairs will broaden its clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Department Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
- Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Center for Molecular Medicine, UMC Utrecht & Utrecht University, Utrecht, the Netherlands.
ORCID-Profile: Meta H M Diekstra, Eugène T P Verwiel, Alex Janse, Alwin D R Huitema, Lidwien M Hanff, Bastiaan B J Tops, Patrick Kemmeren, Jayne Y Hehir-Kwa
Förderung
- Stichting Prinses Máxima Centrum Foundation
Zitieren
APA
Diekstra, M. H. M., Biesot, N., Donders, J., Verwiel, E. T. P., Janse, A., Huitema, A. D. R., Hanff, L. M., Tops, B. B. J., Kemmeren, P., & Hehir-Kwa, J. Y. (2026). Analytical Validation of an Annotation Tool for WGS‐Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology. Clinical and Translational Science, 19(4). https://doi.org/10.1111/cts.70540
Vancouver
Diekstra MHM, Biesot N, Donders J, Verwiel ETP, Janse A, Huitema ADR, et al. Analytical Validation of an Annotation Tool for WGS‐Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology. Clinical and Translational Science. 2026;19(4). doi:10.1111/cts.70540
BibTeX
@article{Diekstra2026,
author = {Diekstra, Meta H M and Biesot, Nienke and Donders, Julie and Verwiel, Eugène T P and Janse, Alex and Huitema, Alwin D R and Hanff, Lidwien M and Tops, Bastiaan B J and Kemmeren, Patrick and Hehir-Kwa, Jayne Y},
title = {Analytical Validation of an Annotation Tool for WGS‐Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology},
journal = {Clinical and Translational Science},
year = {2026},
volume = {19},
number = {4},
doi = {10.1111/cts.70540}
}
EUVIMED